Exploring 3 High Growth Tech Stocks in Sweden
In This Article:
As Sweden's Riksbank reduces borrowing costs, the Swedish tech sector is poised for potential growth amidst favorable economic conditions. In this article, we will explore three high-growth tech stocks in Sweden that stand out due to their innovative capabilities and strong market positioning.
Top 10 High Growth Tech Companies In Sweden
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Truecaller | 20.32% | 21.61% | ★★★★★★ |
| Fortnox | 20.18% | 22.60% | ★★★★★★ |
| Bonesupport Holding | 33.76% | 31.20% | ★★★★★★ |
| Xbrane Biopharma | 58.82% | 99.79% | ★★★★★★ |
| Skolon | 31.76% | 121.72% | ★★★★★★ |
| Yubico | 22.52% | 43.69% | ★★★★★★ |
| Hemnet Group | 20.13% | 25.41% | ★★★★★★ |
| Sileon | 45.80% | 116.53% | ★★★★★★ |
| BioArctic | 39.57% | 102.80% | ★★★★★★ |
| KebNi | 34.75% | 86.11% | ★★★★★★ |
Below we spotlight a couple of our favorites from our exclusive screener.
Better Collective
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Better Collective A/S, along with its subsidiaries, operates as a digital sports media company in Europe, North America, and internationally with a market cap of SEK14.49 billion.
Operations: The company generates revenue primarily through its Publishing and Paid Media segments, with Publishing contributing €245.06 million and Paid Media €109.72 million.
Better Collective's recent financial performance highlights its strong growth trajectory, with Q2 2024 sales reaching €99.12 million, a 27% increase from the previous year. Net income for the same period rose to €10.29 million, up from €8.3 million. The company's R&D expenses have consistently driven innovation in their software offerings, contributing to their revenue growth of 15% annually and earnings forecasted to grow at an impressive rate of 45.5%. Additionally, Better Collective has initiated a share repurchase program worth €2.4 million to cover acquisition obligations, reflecting confidence in its future prospects and commitment to shareholder value.
-
Get an in-depth perspective on Better Collective's performance by reading our health report here.
-
Evaluate Better Collective's historical performance by accessing our past performance report.
BioInvent International
Simply Wall St Growth Rating: ★★★★★☆
Overview: BioInvent International AB (publ) is a clinical-stage company focused on discovering, researching, and developing novel immuno-modulatory antibodies for cancer treatment globally, with a market cap of SEK2.55 billion.
Operations: BioInvent International generates revenue primarily from developing antibody-based drugs, amounting to SEK61.15 million. The company focuses on cancer treatment through novel immuno-modulatory antibodies across various regions including Sweden, Europe, and the United States.